Francesco Cortiula

846 total citations
38 papers, 324 citations indexed

About

Francesco Cortiula is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Francesco Cortiula has authored 38 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 25 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Francesco Cortiula's work include Lung Cancer Treatments and Mutations (18 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Francesco Cortiula is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Lung Cancer Diagnosis and Treatment (10 papers). Francesco Cortiula collaborates with scholars based in Italy, Netherlands and United States. Francesco Cortiula's co-authors include Lizza Hendriks, Gianpiero Fasola, Dirk De Ruysscher, Els Wauters, Bart Reymen, Johan Vansteenkiste, Fabio Puglisi, Pierre Van Mol, Solange Peters and Alessandro Follador and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Francesco Cortiula

36 papers receiving 323 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Francesco Cortiula 202 170 51 48 35 38 324
M. Guirado 202 1.0× 254 1.5× 54 1.1× 37 0.8× 27 0.8× 24 361
Débora S. Bruno 215 1.1× 128 0.8× 51 1.0× 82 1.7× 32 0.9× 45 352
Humera Khurshid 190 0.9× 137 0.8× 70 1.4× 41 0.9× 80 2.3× 24 342
Valérie Cristina 175 0.9× 101 0.6× 70 1.4× 35 0.7× 44 1.3× 15 364
M. Martín Jiménez 200 1.0× 133 0.8× 27 0.5× 79 1.6× 23 0.7× 56 323
Geòrgia Anguera 136 0.7× 116 0.7× 76 1.5× 48 1.0× 37 1.1× 43 281
Samer Tabchi 214 1.1× 141 0.8× 66 1.3× 33 0.7× 22 0.6× 24 326
Valeria Stati 182 0.9× 99 0.6× 61 1.2× 27 0.6× 43 1.2× 25 319
Jean Torrisi 122 0.6× 91 0.5× 72 1.4× 29 0.6× 67 1.9× 11 307
G. Lopes 198 1.0× 158 0.9× 22 0.4× 48 1.0× 21 0.6× 32 263

Countries citing papers authored by Francesco Cortiula

Since Specialization
Citations

This map shows the geographic impact of Francesco Cortiula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesco Cortiula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesco Cortiula more than expected).

Fields of papers citing papers by Francesco Cortiula

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesco Cortiula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesco Cortiula. The network helps show where Francesco Cortiula may publish in the future.

Co-authorship network of co-authors of Francesco Cortiula

This figure shows the co-authorship network connecting the top 25 collaborators of Francesco Cortiula. A scholar is included among the top collaborators of Francesco Cortiula based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesco Cortiula. Francesco Cortiula is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Remón, Jordi, Paolo Bironzo, Francesco Cortiula, et al.. (2025). De-Escalation Strategies With Immune Checkpoint Blockers in Non–Small Cell Lung Cancer: Do We Already Have Enough Evidence?. Journal of Clinical Oncology. 43(9). 1148–1156. 6 indexed citations
2.
Cortiula, Francesco, Melinda Laine Hsu, Lizza Hendriks, et al.. (2025). Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumab. European Journal of Cancer. 219. 115302–115302. 1 indexed citations
3.
Costa, José Luís, et al.. (2025). Oligometastatic NSCLC: Current Perspectives and Future Challenges. Current Oncology. 32(2). 75–75. 2 indexed citations
4.
Remón, Jordi, Paolo Bironzo, Francesco Cortiula, et al.. (2025). De-escalation strategies with targeted therapies in non-small cell lung cancer. Cancer Treatment Reviews. 139. 102995–102995.
5.
Macerelli, Marianna, et al.. (2024). Antibody–Drug Conjugates in Non-Small Cell Lung Cancer: State of the Art and Future Perspectives. International Journal of Molecular Sciences. 26(1). 221–221. 2 indexed citations
6.
Cereser, Lorenzo, Francesco Cortiula, Annarita Tullio, et al.. (2024). Assessing the impact of structured reporting on learning how to report lung cancer staging CT: A triple cohort study on inexperienced readers. European Journal of Radiology. 171. 111291–111291. 1 indexed citations
7.
Remón, Jordi, Édouard Auclin, Leyre Zubiri, et al.. (2024). Immune checkpoint blockers in solid organ transplant recipients and cancer: the INNOVATED cohort. ESMO Open. 9(5). 103004–103004. 5 indexed citations
8.
Buriolla, Silvia, et al.. (2024). Alectinib for the treatment of papillary thyroid carcinoma harbouring STRN – ALK fusion. European Journal of Cancer. 216. 115193–115193. 1 indexed citations
9.
Cortiula, Francesco, et al.. (2024). Treatment of unresectable stage III non-small cell lung cancer for patients who are under-represented in clinical trials. Cancer Treatment Reviews. 129. 102797–102797. 2 indexed citations
10.
Remón, Jordi, Stephanie P.L. Saw, Francesco Cortiula, et al.. (2023). Perioperative Treatment Strategies in EGFR-Mutant Early-Stage NSCLC: Current Evidence and Future Challenges. Journal of Thoracic Oncology. 19(2). 199–215. 17 indexed citations
11.
Zeng, Haiyan, Dirk K.M. De Ruysscher, Juliette Degens, et al.. (2023). The Association of Gross Tumor Volume and Its Radiomics Features with Brain Metastases Development in Patients with Radically Treated Stage III Non-Small Cell Lung Cancer. Cancers. 15(11). 3010–3010. 5 indexed citations
12.
Cortiula, Francesco, et al.. (2023). Adjuvant durvalumab after concurrent chemoradiotherapy for patients with unresectable stage III NSCLC harbouring uncommon genomic alterations. European Journal of Cancer. 184. 172–178. 10 indexed citations
13.
Cortiula, Francesco, et al.. (2023). Unveiling the Potential of Venn Diagrams as a Helpful Tool for Clinical Reasoning: An Illustrative Case-based Discussion. Current Problems in Diagnostic Radiology. 52(6). 478–481. 1 indexed citations
14.
Buriolla, Silvia, Giacomo Pelizzari, Carla Corvaja, et al.. (2022). Immunotherapy in NSCLC Patients with Brain Metastases. International Journal of Molecular Sciences. 23(13). 7068–7068. 23 indexed citations
15.
Cortiula, Francesco, Dirk De Ruysscher, Richard Canters, et al.. (2022). 113P Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on durvalumab eligibility and safety profile. Annals of Oncology. 33. S85–S85. 1 indexed citations
16.
Maso, Alessandro Dal, Paola Del Bianco, Francesco Cortiula, et al.. (2022). EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience. Journal of Thoracic Disease. 14(9). 3364–3375. 4 indexed citations
17.
Cortiula, Francesco, Giulia Pasello, Alessandro Follador, et al.. (2020). A Multi-Center, Real-Life Experience on Liquid Biopsy Practice for EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) Patients. Diagnostics. 10(10). 765–765. 6 indexed citations
18.
Pelizzari, Giacomo, Francesco Cortiula, Michele Bartoletti, et al.. (2020). Platinum-Based Chemotherapy in Older Patients with Non-Small Cell Lung Cancer: What to Expect in the Real World. Drugs & Aging. 37(9). 677–689. 2 indexed citations
19.
Moretto, Roberto, Federica Morano, Elena Ongaro, et al.. (2019). Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component. Clinical Colorectal Cancer. 18(2). 116–124. 7 indexed citations
20.
Cortiula, Francesco, Giovanna De Maglio, Maria Giulia Cangi, et al.. (2019). Third-generation tyrosine kinase inhibitor in the treatment of epidermal growth factor receptor mutated squamous cell lung cancer: a tailored therapy approach. Annals of Translational Medicine. 7(1). 14–14. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Guirado Breakdown of academic impact, for papers by Débora S. Bruno Breakdown of academic impact, for papers by Humera Khurshid Breakdown of academic impact, for papers by Valérie Cristina Breakdown of academic impact, for papers by M. Martín Jiménez Breakdown of academic impact, for papers by Geòrgia Anguera Breakdown of academic impact, for papers by Samer Tabchi Breakdown of academic impact, for papers by Valeria Stati Breakdown of academic impact, for papers by Jean Torrisi Breakdown of academic impact, for papers by G. Lopes
Rankless by CCL
2026